PCA3 and prostate cancer: PCGEM1 was chosen in addition to PCA3 as it has previously been demonstrated to be a prostate tissue-specific, androgen-regulated non-coding RNA that is functionally involved in the development of prostate cancer and significantly over-expressed in AA men with prostate cancer [52,53].